Eiko Lifescience

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE666Q01016
  • NSEID:
  • BSEID: 540204
INR
51.78
2.1 (4.23%)
BSENSE

Nov 20

BSE+NSE Vol: 29.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002696,
    "name": "Eiko Lifescience",
    "stock_name": "Eiko Lifescience",
    "full_name": "Eiko Lifesciences Ltd",
    "name_url": "stocks-analysis/eiko-lifescience",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "51.78",
    "chg": 2.1,
    "chgp": "4.23%",
    "dir": 1,
    "prev_price": "49.68",
    "mcapval": "72.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540204,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 5,
    "indexname": "",
    "isin": "INE666Q01016",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "29.15 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/eiko-lifescience-1002696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4246418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/EikoLifescience_mojoScore_4246418.png",
        "date": "2026-11-01 10:10:05",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4231852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/EikoLifescience_mojoScore_4231852.png",
        "date": "2026-10-21 10:10:02",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4220898",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/EikoLifescience_mojoScore_4220898.png",
        "date": "2026-10-10 10:10:05",
        "description": "Eiko Lifesciences Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-4208536",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EikoLifescience_mojoScore_4208536.png",
        "date": "2026-09-29 10:10:03",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4196306",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EikoLifescience_mojoScore_4196306.png",
        "date": "2026-09-17 10:10:04",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 September 2026, providing investors with the most recent insights into the company’s performance and outlook."
      },
      {
        "title": "Eiko Lifesciences Ltd Falls to 52-Week Low of Rs 43 as Sell-Off Deepens",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/eiko-lifesciences-ltd-stock-hits-52-week-low-at-rs43-amid-market-downturn-4193674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EikoLifescience_priceRelatedfactors_4193674.png",
        "date": "2026-09-15 13:35:40",
        "description": "For the fourth consecutive session, Eiko Lifesciences Ltd has closed lower, culminating in a fresh 52-week low of Rs 43 on 15 Sep 2026. This marks a 33.3% decline from its 52-week high of Rs 64.44, underscoring sustained selling pressure despite some positive financial signals."
      },
      {
        "title": "Eiko Lifesciences Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/eiko-lifesciences-ltd-is-rated-sell-by-marketsmojo-4182479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/EikoLifescience_mojoScore_4182479.png",
        "date": "2026-09-04 10:10:27",
        "description": "Eiko Lifesciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 25,
    "sid": "1002696",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/eiko-lifesciences-1002696"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Restructuring",
      "datetime": "13-Nov-2026",
      "details": "In continuation to our earlier announcement dated 05th November 2026. We wish to inform that the Wholly Owned Subsidiary of the Company namely Eiko Scientific Solutions LLP (LLPIN: ACH-4311) has entered into a Joint Venture by forming a Private Limited Company in the name of Oval Eiko Resources Private Limited.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Nov-2026",
      "details": "Please find enclosed a copy of newspaper publication in the following newspapers dated 06th November 2026 with respect to Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Half-year ended 30th September 2026 approved at the meeting of Board of Directors held on Thursday 05th November 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Restructuring",
      "datetime": "05-Nov-2026",
      "details": "Wholly Owned Subsidiary of the Company namely Eiko Scientific Solutions LLP (LLPIN: ACH-4311) is proposed to enter into a Joint Venture Agreement with Oval Projects Engineering Limited for formation of a new Private Limited Company in the name of Oval Eiko Resources Private Limited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has declared <strong>2%</strong> dividend, ex-date: 20 Sep 17",
          "dt": "2017-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Eiko Lifesciences Ltd has announced <strong>2:3</strong> rights issue, ex-date: 07 Jul 23",
          "dt": "2023-07-07",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Restructuring

13-Nov-2026 | Source : BSE

In continuation to our earlier announcement dated 05th November 2026. We wish to inform that the Wholly Owned Subsidiary of the Company namely Eiko Scientific Solutions LLP (LLPIN: ACH-4311) has entered into a Joint Venture by forming a Private Limited Company in the name of Oval Eiko Resources Private Limited.

Announcement under Regulation 30 (LODR)-Newspaper Publication

06-Nov-2026 | Source : BSE

Please find enclosed a copy of newspaper publication in the following newspapers dated 06th November 2026 with respect to Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Half-year ended 30th September 2026 approved at the meeting of Board of Directors held on Thursday 05th November 2026.

Announcement under Regulation 30 (LODR)-Restructuring

05-Nov-2026 | Source : BSE

Wholly Owned Subsidiary of the Company namely Eiko Scientific Solutions LLP (LLPIN: ACH-4311) is proposed to enter into a Joint Venture Agreement with Oval Projects Engineering Limited for formation of a new Private Limited Company in the name of Oval Eiko Resources Private Limited.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Eiko Lifesciences Ltd has declared 2% dividend, ex-date: 20 Sep 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Eiko Lifesciences Ltd has announced 2:3 rights issue, ex-date: 07 Jul 23